MFC:NYSEManulife Financial Corporation Analysis
Data as of 2026-04-17 - not real-time
$38.63
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Manulife Financial (MFC) trades at $38.63, comfortably above its 20‑day ($35.48) and 200‑day ($33.72) simple moving averages, and the MACD indicator remains bullish (line > signal, histogram +0.49), suggesting lingering upward momentum. However, the RSI of 75 signals an overbought condition, the daily volume is trending down, and the price is flirting with the near‑term resistance around $39.02, which could prompt a short‑term pullback.
On the fundamentals side, the stock appears markedly undervalued: a forward P/E of 10.7 is well below the industry average of 17.5, the dividend yield sits at a healthy 3.4% with a 57% payout ratio, and the DCF‑derived fair value of $172.45 dwarfs the current price. Recent earnings momentum – an 8% rise in core EPS and >20% growth in Contractual Service Margin across the insurance segment – combined with a strong cash position ($32.1B) and manageable debt, supports a longer‑term buy case despite a modest revenue decline.
On the fundamentals side, the stock appears markedly undervalued: a forward P/E of 10.7 is well below the industry average of 17.5, the dividend yield sits at a healthy 3.4% with a 57% payout ratio, and the DCF‑derived fair value of $172.45 dwarfs the current price. Recent earnings momentum – an 8% rise in core EPS and >20% growth in Contractual Service Margin across the insurance segment – combined with a strong cash position ($32.1B) and manageable debt, supports a longer‑term buy case despite a modest revenue decline.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory
- Price near resistance at $39.02
- Decreasing volume trend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E of 10.7 vs industry 17.5
- Strong cash generation and 3.4% dividend yield
- Recent 8% EPS growth and insurance CSM >20%
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable dividend with 57% payout ratio
- Robust balance sheet and diversified geographic exposure
- Revenue contraction risk offset by stable earnings and cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth-34.90%
Profit Margin18.67%
P/E Ratio17.3
ROE11.49%
ROA0.54%
Debt/Equity48.35
P/B Ratio1.9
Op. Cash Flow$32.1B
Free Cash Flow$20.8B
Industry P/E17.5
Technical Analysis
TrendNeutral
RSI75.3
Support$33.49
Resistance$39.02
MA 20$35.48
MA 50$35.55
MA 200$33.72
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39
Valuation
Fair Value$172.45
Target Price$34.74
Upside/Downside-10.06%
GradeUndervalued
TypeBlend
Dividend Yield3.40%
Risk Assessment
Beta0.97
Volatility21.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.